Announcements Trials
Browse Landscape

Phase

Phase 3 8Phase 2 2Phase NA 1Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Lymphoma, Large B-Cell, Diffuse 8Sarcoma 7Osteosarcoma 4Lymphoma 4Wilms Tumor 3Neuroectodermal Tumors, Primitive, Peripheral 3Neuroblastoma 3Neoplasms 3Carcinoma, Renal Cell 3Unspecified Adult Solid Tumor, Protocol Specific 2Retinoblastoma 2Optic Nerve Glioma 2Melanoma 2Medulloblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Hodgkin Disease 2Carcinoma, Hepatocellular 2Astrocytoma 2Waldenstrom Macroglobulinemia 1Uveal Melanoma 1Thrombocytopenia 1Testicular Neoplasms 1Stomach Neoplasms 1Solid Tumors 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Rhabdoid Tumor 1

Interventions

Doxorubicin 4ribociclib 2belinostat 2Radiotherapy 2siremadlin 1selinexor 1sargramostim 1romidepsin 1peposertib 1pembrolizumab 1liposomal doxorubicin 1ixazomib 1eribulin 1cixutumumab 1avelumab 1Trabectedin 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Magnetic Resonance Spectroscopy 1Ifosfamide 1Histamine H2 Antagonists 1Gemcitabine 1Fulvestrant 1Fluorouracil 1Famotidine 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Celecoxib 1Biopsy 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Liposarcoma × Ifosfamide × Clear all
NCT00030784 2012-09-24

Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Completed
28 enrolled
Sarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡